| James Robert Mcwilliams, ANP | |
|
403 Morrow St N Ste F, Mena, AR 71953-4324 | |
| (479) 437-6080 | |
| (479) 437-6079 |
| Full Name | James Robert Mcwilliams |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 403 Morrow St N Ste F, Mena, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659641496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A03647 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jmac Medical Pllc | 3971997016 | 2 |
News Archive
Obesity is known to cluster in families, but most studies to date are limited to two generations. A new Pediatric Obesity study is the first to prospectively examine the relationship between grandparent and grandchild abdominal obesity.
Engineered ingestible molecular traps created from mesoporous silica particles (MSPs) introduced to the gut can have an effect on food efficiency and metabolic risk factors. The results from studies on mice, published in Nanomedicine, demonstrate the potential to reduce the energy uptake into the body and could lead to new treatments for obesity and diabetes.
Today, AstraZeneca and Vanderbilt University announced they have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer's disease and schizophrenia.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.
› Verified 8 days ago
| Entity Name | Jmac Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043965734 PECOS PAC ID: 3971997016 Enrollment ID: O20220307000400 |
News Archive
Obesity is known to cluster in families, but most studies to date are limited to two generations. A new Pediatric Obesity study is the first to prospectively examine the relationship between grandparent and grandchild abdominal obesity.
Engineered ingestible molecular traps created from mesoporous silica particles (MSPs) introduced to the gut can have an effect on food efficiency and metabolic risk factors. The results from studies on mice, published in Nanomedicine, demonstrate the potential to reduce the energy uptake into the body and could lead to new treatments for obesity and diabetes.
Today, AstraZeneca and Vanderbilt University announced they have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer's disease and schizophrenia.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Robert Mcwilliams, ANP 403 Morrow St N Ste F, Mena, AR 71953-4324 Ph: (479) 437-6080 | James Robert Mcwilliams, ANP 403 Morrow St N Ste F, Mena, AR 71953-4324 Ph: (479) 437-6080 |
News Archive
Obesity is known to cluster in families, but most studies to date are limited to two generations. A new Pediatric Obesity study is the first to prospectively examine the relationship between grandparent and grandchild abdominal obesity.
Engineered ingestible molecular traps created from mesoporous silica particles (MSPs) introduced to the gut can have an effect on food efficiency and metabolic risk factors. The results from studies on mice, published in Nanomedicine, demonstrate the potential to reduce the energy uptake into the body and could lead to new treatments for obesity and diabetes.
Today, AstraZeneca and Vanderbilt University announced they have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer's disease and schizophrenia.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.
› Verified 8 days ago
Terri L Barrada, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Gretchen Laurel Goodnight, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 403 Morrow St N Ste D, Mena, AR 71953 Phone: 479-437-6080 Fax: 479-437-6079 | |
Lindy Kaye Jumper, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Kimberly Diane Nance, APRN, BC, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1706 Highway 71 N, Mena, AR 71953 Phone: 479-394-4800 Fax: 479-394-4805 | |
Ocean Miranda Brewer, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1210 Dequeen St, Mena, AR 71953 Phone: 479-394-5068 Fax: 479-394-5626 | |
Sandy Morgan, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1706 Highway 71 N, Mena, AR 71953 Phone: 479-394-1500 Fax: 479-394-1525 | |
Mrs. Debra Inevia Fairless, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1210 Dequeen St, Mena, AR 71953 Phone: 479-394-5068 Fax: 479-394-5626 |